Navigation Links
Antibiotic therapy improves moderate exacerbations of mild-to-moderate COPD
Date:9/7/2012

Antibiotic treatment with amoxicillin/clavulanate improves moderate exacerbations in patients with mild-to-moderate chronic obstructive pulmonary disease (COPD) and significantly prolongs the time between exacerbations, according to a new study from researchers in Spain.

"The existing evidence for antibiotic therapy in non-severe exacerbations of COPD is weak," said lead author Carl Llor, MD, PhD of the University Rovira i Virgili in Tarragona, Spain. "The results of our multicenter, randomized, double-blind, placebo-controlled trial show that antibiotic treatment is more effective than placebo in these patients, with an absolute difference in cure rates of 14.2%, and that the median time to next exacerbation is prolonged with antibiotic treatment, compared with placebo, from 160 to 233 days."

The findings were published online ahead of print publication in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

A total of 310 patients were enrolled in the study and randomized to receive either amoxicillin/clavulanate (500/125 mg) or placebo three times daily for eight days. All participants were at least 40 years old and had a spirometrically-confirmed diagnosis of mild-to-moderate COPD. The primary endpoint was clinical cure at the end of therapy visit.

A total of 117 patients in the amoxicillin/clavulanate group (74.1%) and 91 in the placebo group (59.9%) were considered cured at follow-up. Median time to next exacerbation was significantly longer in the amoxicillin/clavulanate group. Clinical success, defined as either cure or improvement, was achieved in 90.5% of the antibiotic-treated group, compare with 80.9% of the placebo group. Capillary C-reactive protein (CRP) at a cutoff of 40 mg/l was found to be an excellent predictor of clinical outcome; patients with CRP levels below 40 mg/l were significantly more likely to be cured without the use of antibiotics.

The stu
'/>"/>

Contact: Nathaniel Dunford
ndunford@thoracic.org
212-315-8620
American Thoracic Society
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Environmental Gene-Swapping May Play Part in Antibiotic Resistance
2. Antibiotic Use in Infants Tied to Overweight Later: Study
3. A nonantibiotic approach for treating urinary tract infections
4. Two Antibiotics Linked to Liver Injury in Elderly
5. Gonorrhea Resistant to All But One Antibiotic: CDC
6. Timing of antibiotics important in reducing infections after C-section
7. Researchers unveil molecular details of how bacteria propagate antibiotic resistance
8. VCU medical team recommends preventive antibiotic for COPD sufferers
9. Study examines role of seasonal prescribing changes in antibiotic resistance
10. Trivedi Beef, LLC Announces Breakthrough Beef Industry Data without the use of Antibiotic Drugs, Hormones or Steroids
11. A non-antibiotic approach for treating urinary tract infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2014)... York (PRWEB) August 23, 2014 ... filed on behalf of individuals who were ... hip replacement line continue to move forward in ... Bernstein Liebhard LLP reports. According to an Order ... bellwether trial program that would allow the litigation’s ...
(Date:8/23/2014)... 23, 2014 On Monday, August 18th, ... data breach suffered by Community Health Systems, which ... of 4.5 million records containing Personally Identifiable Information (PII) ... to Mandiant, who was engaged to investigate the incident, ... advanced group of cyber attackers based in China, who ...
(Date:8/23/2014)... The MPWMD Board of Directors voted on Monday, August 18th ... of water for commercial and industrial properties. This was ... Archworks, LLC in Carmel, California. , This is a ... district in the State of California has approved this technology ... this time can now be used as a sole source ...
(Date:8/23/2014)... Pixel Film Studios, a leader of Final Cut Pro ... Vol.3, a customizable title tool for FCPX , ... dragging ProIntro Vol.3 in their timeline" says Christina Austin, CEO ... saver and i think our users will agree" , ProIntro ... made with Final Cut Pro X users in mind. Achieve ...
(Date:8/23/2014)... 2014 Dealing with a drug or alcohol ... the addict is a child. Adolescent addiction has been an ... time, but a new helpline is now providing a valuable ... to find a real addiction recovery center. , The Troubled ... impact in the community. By calling (404) 975-2762, parents and ...
Breaking Medicine News(10 mins):Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 2Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 3Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 4Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 2Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 3Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 4Health News:Historical Moment in the Monterey Peninsula, Brings Drought Relief Solution to California, with the Help of EcoloBlue and AWG Technology 2Health News:A new plugin was announced today, ProIntro Vol.3 from Pixel Film Studios for Final Cut Pro X 2Health News:Atlanta’s New Troubled Teen Helpline Is Making a Difference in the Community 2
... ... Onset Technology® today announce a partnership agreement to provide an advanced paging solution for ... enables Citipage customers to receive pages on their Blackberry smartphone via their current pager ... ...
... known that certain types of bacteria boost the immune ... how bacteria perform this essential task. Senior author ... in a featured article in the June 15, 2010, ... available online. Knight is professor and chair of the ...
... disorder in men , MONDAY, June 14 (HealthDay News) ... insecticides may increase a man,s risk of Parkinson,s disease, ... disease patients and a control group of 482 healthy ... for mutations in a gene called ABCB1 and assessed ...
... some drugs, smoking increased vision problems, studies found , ... helps guard against cataracts, while certain medications raise the ... new studies suggest. , And a third study finds ... another disease that robs people of their sight. , ...
... around 200,000 people in Sweden have been diagnosed with ... be helped by mechanical heart pumps, reveals a thesis ... a total of 99 patients with life-threatening heart failure ... long-term circulatory support., "Two-thirds of these patients survived," says ...
... nurse in The University of Texas MD Anderson Cancer ... the 2010 Ethel Fleming Arceneaux Outstanding Nurse-Oncologist Award, made ... of MD Anderson,s clinical faculty, patient care administration and ... selecting Fields for the annual award, the institution,s highest ...
Cached Medicine News:Health News:Onset Technology and Citipage Ltd. Partner to Deliver Advanced Paging Messages to Smartphones 2Health News:Onset Technology and Citipage Ltd. Partner to Deliver Advanced Paging Messages to Smartphones 3Health News:How bacteria boost the immune system 2Health News:Diet, Meds and Smoking Linked to Eye Disease Risks 2Health News:Diet, Meds and Smoking Linked to Eye Disease Risks 3Health News:Peg Fields to receive MD Anderson's highest nurse-oncologist honor 2Health News:Peg Fields to receive MD Anderson's highest nurse-oncologist honor 3
(Date:8/22/2014)... , Aug. 22, 2014 MC Medical, a subsidiary ... a Columbus, OH medical device company, ... FloShield laparoscopic and robotic visualization system in Japan ... for sale in Japan in the ... experience and an extensive product portfolio in endoscopic surgery market ...
(Date:8/22/2014)... Zacks Equity Research highlights Epizyme (Nasdaq: EPZM - Free ... PNRA - Free Report ) as the Bear of the ... (Nasdaq: FOLD - Free Report ), Sanofi (NYSE: SNY ... Report ). Here is a synopsis of all five ... The biotech bull market is far from over due ...
(Date:8/22/2014)... LA JOLLA , Cali ., Aug. ... Annual International Papillomavirus Conference shows that a therapy being developed ... including the two that cause 70 percent of all cervical ... models, HTI-1968 blocked the replication of HPV-16, HPV-18 and HPV-11 ... Thomas Broker , Ph.D., who presented the findings at ...
Breaking Medicine Technology:MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 3Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 4Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 5Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 6Study shows Hera Therapeutics experimental compound shuts down human papillomavirus that causes most cervical cancer 2
... CARMEL, Ind., Aug. 23, 2011 After several years ... device firms, Avant Healthcare Marketing has opened offices on ... expansion for the Midwest medical communications agency. ... Rod Julian, Strategic Brand Network Director for Avant. "But ...
... England, August 23, 2011 KalVista Pharmaceuticals ("KalVista"), ... edema (DME), has raised £8 million in a series A ... Life Sciences. The Company is developing novel, small ... the treatment of DME, a leading cause of adult visual ...
Cached Medicine Technology:Avant Healthcare Marketing Announces West Coast Expansion 2KalVista Pharmaceuticals Launched With £8 Million in Series A Funding to Develop Novel Class of Drugs for Diabetic Macular Edema 2KalVista Pharmaceuticals Launched With £8 Million in Series A Funding to Develop Novel Class of Drugs for Diabetic Macular Edema 3KalVista Pharmaceuticals Launched With £8 Million in Series A Funding to Develop Novel Class of Drugs for Diabetic Macular Edema 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: